Shares of Stardust Power Inc. (NASDAQ:SDST – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating, two have issued a buy rating and two have assigned a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $51.1250.
SDST has been the topic of a number of research analyst reports. Wall Street Zen cut Stardust Power to a “strong sell” rating in a research report on Saturday, September 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Stardust Power in a research report on Wednesday, October 8th.
Read Our Latest Research Report on SDST
Institutional Trading of Stardust Power
Stardust Power Price Performance
Stardust Power stock opened at $6.10 on Thursday. Stardust Power has a 1-year low of $1.42 and a 1-year high of $83.00. The stock has a market cap of $51.61 million, a PE ratio of -1.09 and a beta of 0.18. The stock’s fifty day moving average is $3.68 and its two-hundred day moving average is $4.35.
Stardust Power (NASDAQ:SDST – Get Free Report) last posted its quarterly earnings results on Wednesday, August 13th. The company reported ($0.60) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.30). On average, research analysts expect that Stardust Power will post -0.63 earnings per share for the current fiscal year.
Stardust Power Company Profile
Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.
Read More
- Five stocks we like better than Stardust Power
- 3 Stocks to Consider Buying in October
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is a Low P/E Ratio and What Does it Tell Investors?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Stardust Power Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stardust Power and related companies with MarketBeat.com's FREE daily email newsletter.